Form 4 for BNTC Benitec Biopharma Inc.
Accepted 2023-08-14 00:00:00 ET · period of report 2023-08-11 · accession 0000899243-23-018119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-14 | 2023-08-11 | BNTC | Boston Megan | Executive Dir, Dir | P - Purchase | — | +25.9K | 25.9K | New | — |
| D | 2023-08-14 | 2023-08-11 | BNTC | Boston Megan | Executive Dir, Dir | P - Purchase | — | +25.9K | 25.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-11 | P | A | 25,907 | — | 25,907 | D | — | — | (F1) Represents shares of common stock, par value $0.0001 per share (the "Common Stock") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93. |
| 2 | Derivative | Common Warrants (right to buy) | 2023-08-11 | P | A | 25,907 | — | 25,907 | D | $3.86 · 2023-08-11 to 2028-08-11 | 25,907 Common Stock | (F1) Represents shares of common stock, par value $0.0001 per share (the "Common Stock") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93. |